Toxocariasis is a zoonotic parasitic disease that is endemic throughout the United States. Toxocariasis is caused by the dog and cat roundworms, Toxocara cani and Toxocara cati, respectively. In humans, Toxocara infection occurs mainly in children and can lead to significant morbidity causing damage to a range of organs, including the lungs, liver, or eyes. Few resources and little education have been dedicated to furthering clinicians' understanding of this under-recognized public health problem, and toxocariasis has been referred to as a neglected parasitic infection in the United States [1] . Increasing knowledge of toxocariasis will enable pediatricians to recognize the disease in their patients, initiate appropriate treatment, and educate patients and parents on how to avoid becoming infected.
TRANSMISSION
The toxocariasis transmission cycle begins when an infected dog or cat sheds unembryonated eggs in their feces ( Figure 1 ). Once released into the environment, eggs are not immediately infectious. Between 2 and 4 weeks are required for embryonation to occur depending on ambient temperature and humidity of the external environment [2] . Toxocara eggs are hardy as demonstrated by larval development at ambient temperatures as low as 10°C [3] .
Humans and other animals become infected when they ingest infectious Toxocara eggs in soil contaminated by dog or cat feces. Areas that are frequented by animals, such as playgrounds or sandboxes, are likely to be contaminated. Children are at high risk for infection when they visit these areas and ingest contaminated soil due to their play habits and poor hygiene. Once inside the human intestine, Toxocara larvae hatch but do not undergo further maturation into adult worms; instead, the larvae burrow through the intestinal wall into blood vessels and then migrate to various organs in the body. In contrast, when a dog or cat ingests infectious Toxocara eggs, the larvae mature into adult worms in the intestines. The adult worms lay eggs that are then passed into the environment in the animal's feces. Although a less common route of transmission, humans also can become infected with Toxocara by eating undercooked meat from an animal infected with Toxocara larvae. Infected humans cannot transmit toxocariasis to others because humans do not excrete eggs.
EPIDEMIOLOGY
The incidence and prevalence of toxocariasis in the United States is unknown. Unfamiliarity with the disease among healthcare providers and lack of a consistent laboratory-confirmed case definition make identification and confirmation of cases difficult. A few studies of a small number of patients have attempted to quantify the prevalence Toxocara infection among patients with uveitis in the United States with reported prevalence rates of approximately 1% in the studied populations [4, 5] . A large national sample among people 6 years of age conducted in 1988 through 1994 revealed that 14% had Toxocara antibodies, which suggests previous exposure. Although this study confirmed that Toxocara antibody was commonly present within the US population, a positive serology result does not mean that clinical disease developed at the time of infection or will develop in the future [6] . In the same study, numerous factors including elevated blood lead levels, poverty, and lower education status were associated with positive Toxocara serology results. Seroprevalence also was significantly higher in non-Hispanic blacks compared with non-Hispanic whites. Risk factors for serologic evidence of Toxocara infection include association with puppies <3 months of age or residing in warmer areas (eg, the Southeast) [7] . A history of pica or geophagia (eating soil) has also been strongly associated with increased risk for Toxocara infection. Some studies have shown that persons with toxocariasis are more likely to be male; however, this likely is related to males having a higher seroprevalence and not to a higher likelihood of developing clinical manifestations compared with females [4] .
The epidemiology of toxocariasis is complex because disease transmission involves multiple factors including prevalence of infection in animal hosts and contamination levels in the environment. A large multiyear retrospective study involving over 1.2 million dogs in private veterinary clinics in 44 states revealed that 5% had Toxocara eggs in their stool [8] . Results showed an increased likelihood for infection in dogs <6 months of age and a decreased likelihood for infection in dogs living in the Mountain region of the United States. A study using similar methods tested approximately 400 000 cats and demonstrated the prevalence of Toxocara eggs in cat stool specimens to be 2.9% [9] . Based on the rates in these studies, at least 3.7 million pet dogs and 2.6 million pet cats would have been excreting Toxocara eggs in the United States at the time of the study [8, 9] . Prevalence of shedding among the millions of feral cats and dogs is unknown but undoubtedly higher.
Researchers have conducted multiple studies in an attempt to estimate where Toxocara eggs are most likely to present in the environment. In the United States, rates ranging from 0.3% in public parks in New Jersey to 39% in sandbox samples in Kansas have been reported [10, 11] . The majority of environmental studies have focused on sampling public parks, although there is great variability in what type of samples (eg, soil, sand, or animal feces) were collected for examination, which might explain the wide range of estimates that have been published [2] . Environmental contamination with Toxocara eggs is widespread in the United States; infectious eggs have been found in areas ranging from backyard soil samples to debris collected at sewage treatment plants, with higher concentrations of infectious eggs found in areas where dogs or cats reside [12] [13] [14] . Factors that influence the viability of Toxocara eggs include the type of top soil present, with clay-based soils providing a protective environment for larvae survival. Although Toxocara larvae die below −15°C and larval development does not occur at temperatures below 10°C, infectious eggs have been found in all regions of the United States, and reports of eggs retaining infectivity through the winter have been published [3] .
CLINICAL MANIFESTATIONS Background
In 1950, Wilder [15] examined a collection of preserved enucleated eyes that had been removed from children diagnosed with retinoblastoma; instead of finding tumors in some of eye specimens, she discovered the presence of nematode larvae. Her work led Nichols to identify the nematode as Toxocara canis in 1956 [15] . Around the same time, Beaver et al [16] first defined visceral toxocariasis as a clinical syndrome when they reported on 3 patients with eosinophilia and a variety of clinical manifestations including fever, cough, anorexia, and hepatomegaly. Currently, visceral toxocariasis and ocular toxocariasis are 2 recognized clinical syndromes resulting from infection with Toxocara (Table 1 ). In addition, a third category, called covert or common toxocariasis, has been proposed to describe mild nonspecific symptoms resulting from Toxocara infection. The likelihood and type of clinical manifestations from infection with Toxocara are determined by the parasite load, the migratory pathway of the larvae, and the host's immune response to the parasite. Patients typically do not present with symptoms of both visceral and ocular toxocariasis, although occasional cases have been reported [17] . Of note, many publications and textbooks refer to visceral toxocariasis as visceral larva migrans, and ocular toxocariasis as ocular larva migrans. However, the terms visceral larva migrans and ocular larva migrans can be misleading because clinical manifestations from other parasitic diseases, such as baylisascariasis or 
• Increase awareness and educate patients and parents how to avoid Toxocara infection • Take dogs and cats to veterinarian for routine deworming (especially younger animals) • Promptly remove dog or cat feces to reduce likelihood of Toxocara egg embryonation • Promote good hand hygiene and teach children not to eat soil ascariasis, are also caused by migrating larva; the terms visceral toxocariasis and ocular toxocariasis are specific to Toxocara infection.
Visceral Toxocariasis
Limited data are available on the incidence of visceral toxocariasis. Study of visceral toxocariasis is challenging because there is no standardized case definition, and current knowledge regarding clinical disease resulting from Toxocara infection mainly relies on case reports and retrospective cohort studies including small numbers of patients. The symptom complex and severity of clinical presentation is highly variable resulting in under recognition of the disease and delayed confirmation of diagnosis. A literature review for publications from 1952 through 1972 revealed only 970 reported visceral toxocariasis cases in Western countries [18] . The relatively high seroprevalence of antiToxocara antibody in the US population suggests that many more cases are either minimally (or asymptomatic) undiagnosed or not reported in the literature.
Visceral toxocariasis occurs primarily in young children; studies have shown that most children with toxocariasis are between 2 and 7 years old [19] . The 3 most common organs or body systems affected by Toxocara are lungs, liver, and central nervous system. Presenting symptoms may be nonspecific and include fever, fatigue, anorexia, or lymphadenopathy. Pulmonary symptoms (eg, cough, shortness of breath, or wheezing) and abdominal symptoms (eg, abdominal pain, hepatomegaly, or splenomegaly) may be present when larvae migrate to the lungs or abdominal organs, respectively. Toxocara larvae can also migrate to the nervous system; neurologic findings are diverse and nonspecific and include acute disseminated encephalomyelitis, meningoencephalitis, cerebritis, or eosinophilic meningitis [20] [21] [22] . Seizures are often a presenting symptom when the central nervous system is involved. Although rare, cardiac manifestations such as myocarditis or pericardial effusions resulting from Toxocara infection have been reported [23, 24] . Some studies have found an association between Toxocara infection and diminished lung function, increased risk for asthma, cognitive changes, or adverse neuropsychological effects [25] . Whether Toxocara infection plays any significant role in the pathogenesis of common chronic illnesses (such as some types of asthma) is unknown.
Ocular Toxocariasis
Ocular disease occurs when a Toxocara larva migrates through the blood system and enters the posterior segment of the eye, causing inflammatory changes that may lead to permanent scarring. Compared to patients with visceral toxocariasis, patients with ocular toxocariasis are usually slightly older; studies have reported mean ages ranging from 8 to 16 years [4, 26] . The majority of patients with ocular toxocariasis have unilateral disease, although cases of bilateral disease have been reported [4] . Vision loss or blurry vision is the most common presenting complaint. Pediatric patients also may present with leukocoria, strabismus, photophobia, eye pain, or eye redness. Although no single ophthalmologic sign or symptom is pathognomonic for confirming the diagnosis, certain clinical findings are highly suggestive of Toxocara infection; these include posterior pole granuloma, peripheral granuloma, or subretinal granulomatous mass. Retinal detachment, vitritis, anterior uveitis, scotoma, or leukocoria also may be present.
DIAGNOSIS
In both visceral and ocular toxocariasis, diagnosis is typically confirmed by a combination of presenting clinical signs and symptoms, assessment of risk factors, and laboratory results. Clinical laboratory findings consistent with Toxocara infection include eosinophilia, hypergammaglobulenimia, and elevated isohemagluttinin A and B titers; however, none of these laboratory findings are specific for Toxocara infection, and none of these findings are present in some patients with visceral or ocular toxocariasis suspected on the basis of antibody testing. In patients with ocular toxocariasis, laboratory results are often normal, likely because of smaller larvae burdens and less prominent systemic immune responses. Diagnosis of ocular toxocariasis is therefore typically made by clinical presentation. Stool examination for ova and parasites is not suitable to diagnose Toxocara infection because larvae do not develop into adult worms and eggs are not excreted in human feces.
Serologic testing for antibodies against Toxocara is available in laboratories throughout the United States. The recommended test for toxocariasis is an enzyme immunoassay using Toxocara excretory-secretory antigens to detect immunoglobulin G antibodies against the Toxocara larvae. In a study of patients presumed to have either visceral or ocular toxocariasis, the sensitivity of the test was 78% for visceral toxocariasis and 73% for ocular toxocariasis; at a titer 32 [27] . Specificity of serologic testing for ocular toxocariasis is >90% when ocular fluid is tested. A positive serologic test results does not necessarily indicate current active infection; however, a significant rise in titers on repeat serologic testing is useful for confirming active infection.
TREATMENT
Current recommendations for treatment of toxocariasis are based on clinician experience and a handful of small studies. Definitive guidelines for the treatment of toxocariasis have not been established because no randomized controlled trials have been conducted to determine optimal drug, dose, or length of treatment. Studies to establish optimal treatment remain challenging, because of the relatively small numbers of patients identified with toxocariasis, inconsistency in the time from infection to disease presentation, and variability in immune responses to the Toxocara larvae [28] .
Anthelminthic therapy is recommended for all patients with symptomatic visceral toxocariasis. In the United States, recommended treatment for toxocariasis is typically with a benzimidazole (ie, albendazole or mebendazole); however, neither drug has been submitted to the US Food and Drug Administration for an indication to treat toxocariasis [29] . The most commonly recommended treatment schedules are 400 mg of albendazole orally twice a day for 5 days or 100-200 mg of mebendazole orally twice a day for 5 days. Recommended adult and pediatric dosing is the same for each drug. One observational study of more than 100 children with visceral or ocular toxocariasis and treated with a variety of either mebendazole or albendazole regimens showed that most treated children had a decrease in Toxocara antibodies and improvement of symptoms, but no conclusions could be drawn about optimal regimen [30] . Albendazole may be the drug of choice given its better established safety profile in children and potentially better efficacy, although no comparative trials between the 2 drugs have been completed to date [31, 32] . Other treatment options that have been explored include diethylcarbamazine or ivermectin. Diethylcarbamazine is currently not available in the United States, and studies have shown that patients receiving this drug report more adverse effects. The efficacy of ivermectin remains uncertain and further studies are needed [33] .
There is continued debate regarding the benefit of anthelminthic therapy in patients with ocular toxocariasis based on the potential for inflammation caused by dying larvae to lead to permanent damage. Corticosteroids are routinely used in the management of patients with ocular toxocariasis to decrease inflammation and prevent permanent ophthalmologic damage; the benefit is greater in patient with signs of acute inflammation [34] . Corticosteroids may be administered systemically, topically, or by periocular or intraocular routes. Unfortunately, most patients diagnosed with ocular toxocariasis already have signs of permanent damage upon presentation to an ophthalmologist. To treat and prevent late complications of the disease, ophthalmologic surgery may be recommended in some patients; commonly performed procedures include pars plana vitrectomy, scleral buckle surgery, or cataract surgery.
Questions also remain regarding treatment for asymptomatic seropositive patients, because research has shown that Toxocara infection is often self-limiting [19] . In addition, because the immunologic response after treatment can result in more severe clinical manifestations, some experts argue against treatment of asymptomatic patients or patients with mild visceral toxocariasis [28] . In contrast, toxocariasis can be a subchronic condition that lasts as long as the lifespan of the larvae, which could be as long as several years. Therefore, there could be a risk for reactivation, which would be particularly devastating in patients in whom the Toxocara larva may ultimately migrate to the eye or brain [29] .
PREVENTION
Toxocariasis is preventable. Healthcare providers should be aware of signs and symptoms of toxocariasis and educate patients and parents on how to avoid Toxocara infection. Families who own dogs or cats should be encouraged to routinely take their animals to the veterinarian for deworming, because these pets will typically not have symptoms of illness despite shedding Toxocara eggs. This is especially important for families with new kittens or puppies, because younger animals have a higher likelihood of being infected with Toxocara. Animal owners should avoid allowing their pets to deposit waste in areas where children play, or they should promptly remove and properly dispose of dog and cat feces that has been deposited in these places. Enactment of local community laws that enforce immediate pick up and disposal of dog and cat feces should be encouraged. These actions ensure that if Toxocara eggs are present, they do not have enough time to undergo embryonation and become infectious. Veterinarians should provide education to pet owners regarding the risks of Toxocara infection. Even if families do not own animals, parents need to understand that their child can come into contact with soil contaminated with infectious Toxocara eggs, especially in areas frequented by both pets and feral dogs and cats such as parks or playgrounds. Children diagnosed with pica should have underlying causes of the disease identified and treated by their pediatrician to decrease their risk for Toxocara infection. Promoting good hand hygiene and teaching children not to eat soil will decrease their risk for ingesting Toxocara eggs.
